of Clinical and Basic Cardiology
暂无分享,去创建一个
Prichard Bnc | Excerpta Medica | J. Cruickshank | Austria | Basic Cardiology | Pachernegg GmbH | ·. Verlag | Medizin Wirtschaft | A-3003 Gablitz | Pachernegg Gmbh | Prof. B. N. C. Prichard | Prof. B. N. C. Prichard | JM Cruickshank
[1] Bisoprolol , 2020, Reactions Weekly.
[2] A. Battler,et al. Treatment of stable angina , 2007, Heart.
[3] Jeroen J. Bax,et al. The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery , 2000 .
[4] W. Abraham. Beta-blockers: the new standard of therapy for mild heart failure. , 2000, Archives of internal medicine.
[5] J. Cruickshank. Beta-blockers continue to surprise us. , 2000, European heart journal.
[6] L. Poston,et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.
[7] M. Fowler,et al. Clinical Trials of Carvedilol in Heart Failure , 1999, Heart Failure Reviews.
[8] J. Cleland,et al. Carvedilol for Heart Failure: Clinical Trials in Progress , 1999, Heart Failure Reviews.
[9] A. Fletcher,et al. Quality of life in the management of hypertension. , 1999, Clinical and experimental hypertension.
[10] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[11] K. Goa,et al. Nebivolol in the Management of Essential Hypertension , 1999, Drugs.
[12] P. Stone,et al. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. , 1999, The American journal of cardiology.
[13] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[14] M. Weir. The rationale for combination versus single-entity therapy in hypertension. , 1998, American journal of hypertension.
[15] M. Packer,et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.
[16] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[17] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[18] J. Parker. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials. , 1998, European heart journal.
[19] W. Parmley. Optimum Treatment of Stable Angina Pectoris , 1998, Cardiovascular Drugs and Therapy.
[20] A. Hjalmarson,et al. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. , 1997, The American journal of cardiology.
[21] S. Wellek,et al. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study , 1997, BMJ.
[22] W. Ray,et al. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, JAMA.
[23] S. Goldstein. Beta-Blocking Drugs and Coronary Heart Disease , 1997, Cardiovascular Drugs and Therapy.
[24] A. Stewart,et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. , 1997, Archives of internal medicine.
[25] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[26] P. Raskin,et al. Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. , 1996, American journal of hypertension.
[27] K. Jamerson,et al. The impact of ethnicity on response to antihypertensive therapy. , 1996, The American journal of medicine.
[28] G. Bakris,et al. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. , 1996, Archives of internal medicine.
[29] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.
[30] C. Tack,et al. Effects of Insulin on Vascular Tone and Sympathetic Nervous System in NIDDM , 1996, Diabetes.
[31] M. Safar,et al. Effects of antihypertensive drugs on large artery compliance. , 1995, The Netherlands journal of medicine.
[32] V. Papademetriou,et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. , 1995, American heart journal.
[33] B. Meier. [Beta blockers in clinical practice]. , 1995, Praxis.
[34] W. Frishman,et al. First‐Line Therapy Option with Low‐Dose Bisoprolol Fumarate and Low‐Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic Hypertension , 1995, Journal of clinical pharmacology.
[35] B. Strauer,et al. Peripheral vascular effects of beta-blockers. , 1994, European heart journal.
[36] K. Koury,et al. A Multifactorial Trial Design to Assess Combination Therapy in Hypertension: Treatment With Bisoprolol and Hydrochlorothiazide , 1994 .
[37] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[38] D J Reda,et al. Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .
[39] V. Papademetriou,et al. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. , 1993, The American journal of medicine.
[40] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[41] A E Fletcher,et al. Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. , 1992, Hypertension.
[42] H. Black. Metabolic considerations in the choice of therapy for the patient with hypertension. , 1991, American heart journal.
[43] B. L. Wilson,et al. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. , 1990, Journal of human hypertension.
[44] C. Bulpitt,et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. , 1990, Journal of hypertension.
[45] J. Tuomilehto,et al. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.
[46] J. Wikstrand. BETA‐BLOCKERS AND CARDIOPROTECTION–IS THERE ANY GOOD NEWS FROM THE RECENT TRIALS? , 1987, Journal of clinical pharmacy and therapeutics.
[47] J. Tuomilehto,et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.
[48] E. Antman,et al. Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris. , 1987, The American journal of cardiology.
[49] A. Zanchetti,et al. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[50] A. Zanchetti,et al. Double‐Blind Comparison of the Cardioselective &bgr;‐Blockers Bisoprolol and Atenolol in Hypertension: The Bisoprolol International Multicenter Study (BIMS) , 1985, Journal of cardiovascular pharmacology.
[51] MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. , 1985, British medical journal.
[52] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[53] J. Kenny,et al. Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris. , 1985, British heart journal.
[54] A. Quyyumi,et al. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. , 1984, British medical journal.
[55] M. Bassan,et al. The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect. , 1983, Chest.
[56] P. Tanser. Management of stable angina pectoris. , 1977, Canadian family physician Medecin de famille canadien.
[57] T. Pitkäjärvi,et al. The use of clonidine and practolol in the treatment of hypertension. , 1976, Annals of clinical research.
[58] P. Lockwood,et al. [Use of propranolol in treatment of hypertension]. , 1972, Revue medicale de Liege.
[59] P. Gillam,et al. Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise. , 1971, British heart journal.
[60] B. Prichard,et al. Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. , 1966, The American journal of cardiology.
[61] P. Snow. Treatment of acute myocardial infarction with propranolol. , 1966, The American journal of cardiology.
[62] P. Gillam,et al. Use of Propranolol in Angina Pectoris , 1965, British medical journal.
[63] J. A. Robinson. Clinics , 1883, The Dental register.
[64] U. Goldbourt,et al. Are b-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly? , 2017 .
[65] T. Hasegawa. [Mild hypertension]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[66] M. Bristow. beta-adrenergic receptor blockade in chronic heart failure. , 2000, Circulation.
[67] J. Staessen,et al. Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension. , 1999, European heart journal.
[68] M. Moser. A critique of the world health organization-international society of hypertension guidelines for the management of hypertension , 1999 .
[69] S. Julius,et al. Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes. , 1998, Blood pressure. Supplement.
[70] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[71] B. Karlberg,et al. Quality of life in hypertensive patients treated with either carvedilol or enalapril. , 1996, Blood pressure.
[72] C. Dollery,et al. Medical Research Council trial of treatment of hypertension in older adults: principal results. , 1992 .
[73] K. Swedberg,et al. Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study. , 1991, Journal of internal medicine. Supplement.
[74] P. Saul,et al. Comparison of β‐Blockade and ACE Inhibitors in the Treatment of Hypertension , 1990 .
[75] Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.
[76] W. de Oliveira Júnior. [The effects of antihypertensive therapy on the quality of life]. , 1989, Arquivos brasileiros de cardiologia.
[77] D. Gau. MILD HYPERTENSION: IS THERE PRESSURE TO TREAT? , 1988 .
[78] E. Raftery,et al. Combined therapy with verapamil and propranolol in chronic stable angina. , 1982, The American journal of cardiology.
[79] P. Gillam,et al. Discovery of the hypotensive effect of propranolol. , 1976, Postgraduate medical journal.